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Literature Review 
Introduction 
Whole blood transfusion is a widely used treatment in 
a variety of pathologic conditions in many animal species. 
Despite its replacement in recent years by plasma expanders, 
reconstituted platelets, fresh frozen plasma and cryoprecipi- 
tates in the treatment of selected disorders, whole blood still 
enjoys some distinct advantages. Whole blood provides the 
recipient with a balanced electrolyte solution, utilizable 
energy substrates, clotting factors, as well as cellular 
elements. 
Although erythrocytes can be the cause of many adverse 
reactions associated with transfusion, they may be the most 
essential component of the transfusion because of their role 
in carrying oxygen to the tissues. Anemia can occur due to 
hemorrhage, intravascular destruction, bone marrow depression 
or pooling in the microvasculature. If an animal is deprived 
of adequate red cells for too long, death or tissue damage 
will result from anoxia. Problems associated with blood 
transfusions have stimulated research into the hemodynamics 
of red cell exchange and the erythrocyte antigens and serum 
antibodies that precipitate many of these problems. For all 
species studied, the problems of blood group incompatibilities, 
transfusion reactions, and neonatal isoerythrolysis apply to 
varying degrees. Currently, for most domestic animals, infor- 
mation on erythrocyte antigens and their effect on transfusion 
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safety and efficacy is understood and applied in clinical 
situations. 
Cats are among the species in which whole blood trans- 
fusions are most widely practiced for routine treatment. This 
is due in part to the many anemias that affect cats, the ease 
of transfusion, the clinical record of safety and the relative 
inexpense of maintaining donors. Unfortunately, research has 
not provided a sound basis for the widespread use of this 
therapy. There have been studies of the blood grouping 
systems of cats1'2'3 and the methodology of and clinical 
indications for blood transfusions in cats are described,4'5 
but little is known about how the cat reacts to the transfused 
red cells. 
History 
The once popular belief that blood types were only 
important in man has, since the early 1900's, given way to 
research which produced considerable information on blood 
typing, blood transfusion, and the problems associated with 
blood transfusion. Ingebrigsten6 reported the existence of 
isoagglutinins in cat serum, in 1912, in a study on tissue 
transplantation. Of 40 cats examined in groups of 10, iso- 
agglutinins were found in the serum of 6, which reacted to 
the cells of between 1 and 7 of the other cats in their test 
group. No attempt was made to form groups based on the 
occurrence of antibodies. Ottenberg and Thalhimer7 confirmed 
the results of that study and reported the first experimental 
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transfusions in cats. They concluded that isoagglutinins 
in cats are weak antibodies that fluctuate significantly and 
do not form distinct groups, while isohemolysins are not found 
in the blood of normal cats, but can be elicited by trans- 
fusion. It appeared that there were possible groups asso- 
ciated with the induced isohemolysins. 
There was no further research on cat transfusions for 
some years. In that period, the clinical use of blood trans- 
fusion therapy in cats became an accepted practice. Kirk8 
advocated whole blood transfusion to treat the anemia and 
agranulocytosis associated with feline panleukopenia, in 
1948, and explained the mechanics of the exchange process. 
In 1950, Holmes9 undertook the first of two projects to blood 
type cats in Manchester, England. In his first survey, he 
used the isoagglutinin found in the blood of normal cats, 
designated group 0, to type 477 cats. He reported the popu- 
lation to consist of two groups. The larger group (EF) 
exhibited the antigens, designated E and F, on the surface 
of their red cells and made up 97% of the population sample. 
A second group 0, whose serum contained the antibodies to 
those red cell antigens, made up the remaining 3%. In 1952, 
HolmesI surveyed an additional 103 cats and reported a third 
group, F, whose red cells were agglutinated by type 0 serum 
and whose serum weakly agglutinated the cells of group EF. 
The population percentages given in the second survey were 
95% EF, 4% 0 and 1% F. The EF and 0 groups of Holmes correspond 
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to groups A and B respectively, of later studies.2 The one 
cat designated group F corresponds to none found in later 
studies and is unexplainable because the antigens E and F 
seem to be one antigen. In addition to the blood groups, 
Holmes reported that isoagglutinins remained relatively con- 
stant throughout the year and that natural isohemolysins are 
found in normal cat blood. Holmes attempted to make an 
analogy between the blood groups of cats and those of man 
but no firm conclusions were made. 
In 1952, Eyquem and Podliachouk2 surveyed 350 cats and 
reported the existence of two groups, with the population 
consisting of 85% group A and 15% group B. They found normal 
isoagglutinins in 20% of the cats studied and found that 
normal titers of between 1:16 and 1:512 could be increased 
to 1:8000 by isoimmunization. 
A more extensive study of blood group systems of domes- 
tic cats and their mode of inheritance was undertaken by 
Auer and Bell3 in 1981. When they surveyed 1,895 cats in 
Brisbane, Australia, they found 73.3% group A, 26.3% group B 
and .4% of a previously unreported blood group in which the 
erythrocytes contained both antigens and was, therefore, 
designated group AB. By absorbing sera against incompatible 
red cells, they showed that no important subgroups to the 
AB system existed. Anti -A was found to be a strong agglutinin 
and a strong hemolysin, occurring in 95% of group B cats. 
Anti -B was a weak agglutinin and a strong hemolysin, occurring 
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in only 35% of group A cats. The levels of antibodies fluc- 
tuated throughout the study. Although they speculated on two 
hypothetical inheritance patterns, Auer and Bell were unable 
to form any firm conclusions. The simplicity of the AB system 
makes it relatively simple to determine the blood groups in 
a sample of the cat population. Only one small sample of cats 
in the U.S. is reported, which found 18 group A cats and 2 
group B cats in New York City.10 These results could easily 
fit the previously reported population proportions. 
Indications for Transfusion 
Whole blood or reconstituted red blood cell transfusion 
is most often used in cats in the treatment of acute or chronic 
anemias or for maintaining cats with nonresponsive anemias.11 
It is a well accepted adjunct for treating acute blood loss,12 
hemobartonellosis,13 aplastic anemia,14 feline respiratory 
disease complex15 and myeloproliferative disorders16 associated 
with feline leukemia virus. Unlike the dog, fatal bleeding 
rarely occurs in the cat due to trauma and the need for trans- 
fused blood seldom arises during surgical procedures.11 Why 
cats suffer more often and more severely from anemia is not 
known but it is appropriate that cats also seem to have the 
greatest ability to withstand anemia without showing any 
clinical signs.11 When anemia affects the cat to the point 
of debility, blood transfusions may provide the recipient with 
the needed time to respond on its own or simply provide the 
red cells necessary to ameliorate most clinical signs. 
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Although whole blood can be given to supply platelets or 
clotting factors,13 it is preferable to separate plasma or 
platelets for these procedures.17 
The decision of whether to transfuse an anemic cat must 
take many factors into consideration. There is no magic 
degree of anemia at which a transfusion becomes necessary, 
because each cat will differ in its ability to tolerate 
anemia. A cat's ability to tolerate anemia is determined 
partly by the rapidity of onset and the general health of 
the cat. Hemobartonella, for example, can cause a 10-15% 
drop in packed cell volume (PCV) in one day,4 while causing 
fever and otherwise depressing the cat. Chronic anemias 
are, in contrast, characterized by minor decreases of 1-2% 
per day in PCV4 and can be free of other manifestations. The 
more rapid the drop in PCV and hemoglobin (Hb), the more 
debilitating the anemia. Clinical evaluation remains the 
most important deciding factor of whether a transfusion is 
indicated. Schall and Perman18 recommend transfusion if the 
PCV is 12% or less, while Norsworthy4 begins transfusion 
therapy in some cases at a PCV of 15%. Enough blood should 
be given to produce clinical improvement but not so much as 
to suppress erythropoetic stimulus. That dosage is not 
agreed upon by all researchers. Norsworthy4 recommends 
returning the PCV to 18%. Others prefer to give a standard 
dose to the average size cat which they feel has produced 
the best results. Clark states 2-5 ml/lb is usually sufficient. 
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Schall and Perman18 state the arbitrary does of 10-20 ml/kg. 
Flint et a112 gives a standard dose of 40 ml in feline infec- 
tious anemia and Cotter22 calls for a standard dose of 100 ml 
in chronically anemic cats for maintenance. In chronic cases 
where bone marrow response is poor, inhibition of erythro- 
poetic stimulus is not as great a concern. Final judgement 
depends on the amount, the clinician feels produces desired 
results, but which still leaves the cat anemic, so that the 
bone marrow will respond if possible. Whole blood transfusion 
may be contraindicated in autoimmune hemolytic anemia and when 
distinct incompatibility is evident in crossmatching tests. 
Methodology 
The methods of removing and administering blood are 
limited only by feline anatomy and the skill of the clinician. 
With few exceptions the administration of the transfusion will 
not pose a major problem. Donors should be feline leukemia 
virus negative and be free of hemobartonellosis. Blood can 
be taken from the jugular vein, cephalic vein or ventricle of 
the heart. The jugular vein is probably the easiest to iso- 
late and the safest. The heart should be reserved for those 
donors which are terminal. The expense of maintaining a donor 
cat is minimal compared to the usefulness of the procedure. 
The amount of blood taken from a donor varies but a healthy 
cat can lose up to 30% of its blood volume without going into 
shock. Clark states 10 ml/lb can be withdrawn and replaces 
it with plasma expander.5 Thornton19 recommends taking 50-60 
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ml per bleeding and resting the donor for 3 weeks before 
another bleeding. Byars and Divers state that 20% of a cat's 
blood volume of 35 ml/lb may be donated safely. A sacrificial 
donor of average size will yield approximately 175 ml from 
the heart.19 If the blood is to be used immediately, it 
should be collected in heparin, because the safety of citrate 
anticoagulants is questioned in the cat.5 The amount of 
heparin is not critical but it is possible to give too much 
in a large transfusion, approximately .25 ml (1000 units/ml) 
should be used for 10 ml of blood.5 Heparin can be diluted 
in 3 ml of saline to aid in mixing. Heparin will eventually 
be broken down by plasma heparinases and therefore cannot be 
used for storing blood. Acid -citrate -dextrose (ACD) or 
citrate -phosphate -dextrose (CPD) are used for storage, because 
these solutions maintain erythrocyte viability better. It 
has been recommended that dog blood may be stored for 3 weeks 
in ACD at 4°C.21 
Blood can be administered with a needle, but a catheter 
well seated in the cephalic vein is preferable. The rate of 
transfusion is disputed because rapid infusion can result in 
pronounced cardiovascular disturbances and methods of slow 
infusion are difficult to adapt for use in cats. Schall and 
Perman18 recommend a 5 ml/lb/hr rate and Cotter22 states a 
full 100 ml dose can be given in 30 min. in an average size 
cat. If vomiting or excitement occurs, the transfusion should 
be stopped until the cat has recovered. If the blood is cool 
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it should be warmed for rapid transfusion. Tranquilizers 
or anesthetics can be used before transfusion but are gener- 
ally not needed. 
cavity only as a 
erythrocytes are 
Blood should 
last resort. 
absorbed into 
be given in the peritoneal 
Intraperitoneally infused 
the blood,19 but the process 
is usually not fast enough to provide relief 
anemic cat. Thornton20 reports poor results 
dure in puppies and kittens. 
in a severely 
with the proce- 
Transfusion Reactions 
Adverse reactions due to the transfusion of whole blood 
in cats have been alluded to since the first experimental 
transfusions were done. Most are credited to red cell incom- 
patibility, but unfavorable effects could be due to immuno- 
logic reactions to leukocytes, infusion of cold blood, 
infusion of extraneous matter or infusion of toxic amounts 
of anticoagulant. Ottenberg and Thalhimer7 concluded that 
direct transfusion of red cells agglutinable by the recipi- 
ent's serum has no immediate harmful effects. Cells which 
are susceptible to hemolysis by the recipient's serum did 
cause some negative reactions. When transfused with these 
cells the recipients exhibited a marked hemoglobinemia, 
hemoglobinuria, with intravascular hemolysis, phagocytosis, 
a reactive leukopenia and usually glycosuria. Because they 
did not report the existence of natural isohemolysins, all 
of these reactions were in previously transfused cats. 
Thornton19 mentions complications which occurred after single 
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and multiple transfusions and states that information on 
blood groups in cats might help avoid these problems. The 
vast majority of feline transfusions are done with complete 
safety10,22 even on a repeat basis. The caution by most 
investigators, that blood should be crossmatched or repeat 
transfusions avoided, seems to be designed to catch the 
infrequent problem case rather than the rule. 
Despite the widespread use of transfusions in cats, 
only one death caused by transfusion of incompatible blood 
has been reported.23 A feline surgery patient was given 
citrated whole blood two hours after surgery because of 
pallor and a history of anemia. Apparently, it was the 
cat's first transfusion. After infusion of only 4 ml of 
blood, the cat reacted with periods of dyspnea, stretching 
increased heart rate 
15-30 minutes later. 
cient information to 
cell incompatibility 
and force, and retching. 
does not 
Death occurred 
provide suffi- 
death was due to red 
to something in the 
plasma or the anticoagulant solution. The donor cat had 
group A erythrocytes but the recipient's blood group was 
The case report 
conclude whether 
or to a reaction 
unknown, and its anti -A 
results were given. In 
shock reaction occurred 
blood type B given 1 ml 
titer was not measured. No necropsy 
an experimental follow-up severe 
in 17 of 32 unsensitized cats of 
of 50% saline suspension of group A 
cells. No deaths resulted. If the population of cats is 
75% group A and 25% group B,3 then with a randomly chosen 
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donor and recipient, a transfusion of incompatible blood 
should occur 37.5% of the time. Adverse reactions occurred 
in approximately one-half of the group B cats given group A 
erythrocytes and in none of the group A cats given group B 
erythrocytes. An adverse reaction would then be expected 
4.68% of the time with randomly chosen donors. In a clinic 
doing a large number of feline transfusions such a high rate 
of adverse reactions would hardly go unnoticed, unless the 
reaction lacks sufficient manifestations to be noticed 
clinically. Even though the death report and high rate of 
experimental transfusion reactions are questionable, it is 
substantive enough to raise concern about how adverse reactions 
can be prevented. Crossmatching will prevent some but not all 
of the incompatible transfusions, by revealing recipients with 
high titers of antibody against the donors blood group anti- 
gens. Agglutination crossmatch tests are simple and quick to 
perform but hemolytic crossmatches require a source of comple- 
ment not readily available to most clinicians. An even more 
complete, but less feasible solution to the problem would be 
the typing of all donor and recipient cats. 
The citrate in ACD or CPD has also caused problems in 
the transfusion of whole blood to cats.5 Citrate intoxica- 
tions occur in dogs and man.24'25 It is due largely to 
chelation of calcium. Because citrate is metabolized rapidly 
by the liver, rapid infusions of large amounts of citrate are 
needed to produce toxicity in dogs (2-5 ml/kg/min).25 
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Whether the feline liver is less efficient at metabolizing 
citrate or whether cats are more susceptible to the effects 
of decreased serum calcium is not known, but the use of 
citrated blood in cats has been questioned.5 This problem 
can be avoided by restricting use of stored blood and pre- 
serving fresh blood in heparin. If stored blood must be 
used, reconstitution of red cells in saline will decrease 
the amount of citrate infused. The adverse effects of 
citrate can be counteracted by infusion of 1 mg CaC12 per 
10 ml of whole blood infused.24 
The occurrence of neonatal isoerythrolysis in cats 
following blood transfusion is unknown. All of the prerequi- 
sites of the problem have been reported in cats. Colostrum 
can contain levels of antibodies directed against blood group 
antigens2 and red cell antigens are found on the cells of 
the liver and spleen of the fetus.2 Fetal erythrocytes also 
show evidence of antigen development as early as 38 days of 
gestation.3 It is possible, therefore, that transfusions 
which cause antibody development in an intact female, might 
cause colostral antibodies to be present in later pregnancies, 
which could be high enough in titer to cause problems in the 
kittens of a different blood group. Nothing substantive is 
known about the inheritance patterns of feline erythrocyte 
antigens, but "fading kitten syndrome" has been associated 
with an incompatibility reaction between queen and kitten 
due to sensitization with panleukopenia tissue vaccine.26 
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Rationale for Thesis 
The purpose of this study was to determine the life - 
span of erythrocytes after autologous and allogeneic trans- 
fusions in the cat, to determine the role that red cell 
antigens and antibodies against those antigens play in the 
fate of the red cells and to determine the maximum time 
feline blood can be stored. 
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Paper 1. Survival of Erythrocytes After Autologous 
and Allogeneic Transfusion in Cats 
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Summary 
Apparent mean survival time of 14C-cyanate labeled feline 
erythrocytes was determined after autologous and allogeneic 
transfusion. Mean survival time was defined as that time when 
one half of the transfused cells have been removed from cir- 
culation. Autologously transfused cells had a mean survival 
time of 38.0 days + 2.02. Allogeneic transfusion between 
cats of the same blood type showed a near normal mean survival 
time of 30 days. Primary allogeneic transfusion between cats 
of differing blood groups showed a mean survival time between 
10 and 14 days, while repeat transfusions of this type showed 
a mean survival time of less than 5 days. The life -span of 
cross -transfused red cells can be significantly effected by 
blood type. For maximum effectiveness, survival of cells, 
blood transfusions should be between cats of the same blood 
type. First-time transfusions between cats with different 
blood groups can be given safely but erythrocyte life -span 
will be shortened. 
Introduction 
Blood transfusion is one of the most used and discussed 
treatments for a wide variety of ailments in all animal species. 
It contains many elements essential to life. Whole blood or 
reconstituted red cells must be used when treating losses of 
blood or cellular elements of the blood, of a magnitude that 
could seriously compromise an animal's ability to deliver 
oxygen to the tissues. Effective numbers of erythrocytes can 
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be reduced with hemorrhage, intravascular hemolysis, pooling 
in the microvasculature, and bone marrow depression. Trans- 
fusions in cats are especially appropriate, because bone 
marrow depression and neoplastic anemias occur frequently. 
Clinically, many transfusions are performed under a variety 
of conditions1,2 on a regular basis, and although results are 
not always optimal, neither the safety nor the efficacy of 
the practice is seriously questioned. The indications for 
and the mechanics of blood transfusions in cats are well 
outlined,3,4 but very little attention has been directed 
toward the hemodynamics and complications of transfusions. 
Several techniques are available to estimate red cell 
life -span and the normal erythrocyte life -spans of many species 
are known.5'6'7'8 Cells removed from an individual and rein - 
fused into the same individual provide a reliable estimate for 
normal red cell life-span.8 Cells transfused between compati- 
ble humans last approximately as long as normal cells,9 while 
erythrocytes of random cross -transfusions in animals tend to 
have shorter than normal life-spans.5,6,10,11,12 The simplest 
and most widely used of these techniques is 51Cr labeling of 
erythrocytes. Among its other shortcomings, is the fact that 
it reports a T 1/2 that is only useful from a comparative 
point of view. Other methods, DF32P, 14C-glycine and 59Fe 
labeled erythrocytes yield data which can give a concrete 
estimate of normal life -span. The reported erythrocyte life - 
span in cats is 76.2 days13 and 72.6 days,14 for DF32P and 
14C-glycine 
studies respectively. 
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Blood groups occur in cats and isoantibodies to those 
groups are also found in normal cat blood.15,16,17 The cat 
population is approximately 75% group A and 25% group B, 
with group AB occurring rarely.17 Erythrocyte incompati- 
bilities have been incriminated as the cause of complications 
following single and multiple transfusions in cats,18 and 
possibly as a cause of neonatal isoerythrolysis in kittens.19 
Only one death due to blood group incompatibility in a 
transfused feline surgery patient has been reported.20 
The purpose of the present study was to determine the 
life -span of erythrocytes after autologous and allogeneic 
transfusions in the cat, and determine the role that blood 
groups and isoantibodies play in the fate of the transfused 
cells and the safety of the transfusion. 
Materials and Methods 
Five domestic shorthair cats were used in the study. 
The group consisted of one intact male and four intact females 
of various color patterns. To our knowledge none of the cats 
were related and none had received any previous transfusions. 
Initially, the cats were crossmatched against each other. 
A 3 ml blood sample was taken from the jugular vein. Red cells 
were separated by centrifugation, washed twice and diluted 
to 2% with isotonic saline. Washed cell suspension (50 pl) 
was mixed with undiluted serum (100 p1) and incubated for 30 
min. at 37° C, then the mixture was centrifuged at 1000 rpm 
for 1 minute. Agglutination was determined grossly and 
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microscopically. Appropriate controls were used in all 
cases. 
Erythrocyte life -span was determined after autologous 
and allogeneic transfusion. Erythrocytes were labeled in 
vitro with K 14CNO4.a Blood (5 ml/transfusion) was taken 
from the jugular vein into heparin. Red cells were separated 
by centrifugation and reconstituted in sterile isotonic buf- 
fered saline. The labeling preparation (50 pl/ml) was added 
to the red cell suspension and incubated at 37° C for one 
hour with slight agitation. The cells, separated by centri- 
fugation, were washed 3 times in sterile saline and recon- 
stituted to 5 ml. The resulting solution was transfused with 
a cephalic catheter into cats anesthetized with ketamine.b 
The cats were observed closely for post -transfusion reactions. 
Post -transfusion blood samples (1 ml) were taken from the 
jugular vein into heparinized syringes. Samples were taken 
at 30 min, 24 hours, 48 hours and 2-3 times/week. The packed 
cell volume (PCV) of each sample was determined by microhema- 
tocrit and hemoglobin (Hb), as the cyanmethemoglobin derivative. 
The radioactivity was counted by placing whole blood (20 pl) 
onto small pieces of filter paper and decolorizing with 30% 
H202 (.5 ml). After thorough drying, the filter paper was 
aPotassium (14 "C) Cyanate, Amersham/Searle, Arlington 
Heights, Ill. 
bKetaset, Veterinary Products Bristol Laboratories, 
Syracuse, N.Y. 
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immersed in liquid scintillation counting fluidc (10 ml). 
The samples were refrigerated and counted in a Betatrac 6895 
liquid scintillation counter.d The radioactivity is reported 
as counts per minute as a percent of the 24 hour count. The 
data of the autologous transfusions were evaluated using 
linear regression. Mean survival time was defined as the 
time when one half of the transfused cells had been removed 
from circulation, as determined by the regression line. It 
represents approximately one half of the full life -span. 
The cats were blood typed after being sensitized by tri- 
weekly injections of allogeneic whole blood (1 ml) from ran- 
domly selected partners. The cells and serums of the cats 
were tested against each other using the agglutination test 
along with a test for hemolysis. The hemolytic test modified 
the agglutination procedure by adding 50 pl of pooled guinea 
pig complement,e which had been absorbed against pooled cat 
red cells for 5 min. After observing for agglutination, 
complement was added and incubated for 1 hour at 37° C. 
Hemolysis was determined visually at 1 hour and 90 minutes. 
Types were assigned based on the assumption that anti -A was 
cScintisol, Isolab Inc., Akron, Ohio. 
dBetatrac 6895, Tracor Analytic, Inc., Elk Grove 
Village, Ill. 
eGuinea Pig Complement, Lyo & Diluent, Miles, Elkhart, 
Ind. 
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a strong agglutinin and a strong hemolysin while anti -B, a 
strong hemolysin and weak agglutinin.17 
Results 
Erythrocytes transfused autologously declined at an 
approximately linear rate as would be expected with a random 
labeling procedure. The results are plotted in Figure 1. 
There was an initial 10-20% drop in activity between the 30 
min and 48 hr samples probably due to damage to cells during 
the labeling procedure. Most of the nonviable cells are 
removed from circulation within 24 hrs after transfusion.21 
The remaining erythrocytes had a mean survival time of 38.9 
days + 2.02 which corresponds to a life span of 77.8 days. 
Counts in the 0-10% range proved to be unreliable but trans- 
fused cells were essentially gone by day 82 in all four 
transfusions. 
Because crossmatching of cats by agglutination tests 
showed no pronounced incompatibilities, the initial trans- 
fusions were random. In figure 2, three distinct groups of 
results can be seen. Transfusion between cats of the same 
blood type (G) shows an approximately linear decrease in 
number of erythrocytes surviving and a nearly normal mean 
survival time of 30 days corresponding to a life span of 60 
days. First time transfusions between cats of differing blood 
types (D, E, F), show shorter more variable life -spans, with 
a mean survival time of between 10 and 14 days. The number 
of surviving cells dropped below 10% by 15 to 22 days. Second 
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or third transfusions between cats of differing blood types, 
cats which have been previously sensitized to the red cell 
antigens of the transfusion, showed rapid destruction of 
cells. In all cases (A, B, C), there was a mean survival 
time of less than 5 days, with less than 10% of the cells 
surviving at 10, 5.5 and 5 days respectively. Neither signs 
of transfusion reactions, nor hemoglobinemia was observed. 
Blood grouping tests revealed one group B cat which 
developed a high titer agglutinating antibody directed against 
the red cells of the other four cats, which were then desig- 
nated group A. The group A cats sensitized with injections 
of group B blood developed a high titer hemolytic antibody 
against group B red cells, confirming the blood group dis- 
tinctions. 
Discussion 
The present data indicate that the life -span of normal 
feline 
longer 
topes. 
of the 
erythrocytes is 77.8 days + 4.04. That is slightly 
than reports by other investigators using other iso- 
Because 14C-cyanate binds firmly to the hemoglobin 
red cell, it may be a more accurate reflection of 
potential life span. 
The life -span of cross -transfused cells can be affected 
significantly by the blood types. When blood is transfused 
between cats of the same blood type (A or B) erythrocyte 
life -span is almost normal. That indicates that no subgroups 
of consequence occur within the three main blood types in 
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cats, which would cause immunologic destruction of the cells. 
Transfusions of this kind should provide long term benefit 
to the patient. Cross -blood group transfusions into cats not 
previously sensitized to red cell antigens can provide ade- 
quate numbers of red cells with a life -span long enough to 
allow their use in many situations. Recipient cats can 
develop an immunological response to incompatible cells that 
is accompanied by rapid destruction of transfused erythro- 
cytes at approximately 2 weeks. Although adverse reactions 
were not observed in the present experiment with this immune 
response, they can occur. Repeated transfusions between the 
same two individuals or between cats of differing blood types 
may be unwise because cells may not live long enough to bene- 
fit the recipient. An apparent anamnestic response to red 
cell antigens rapidly destroys the incompatible cells. The 
possibility that transfusion reactions or hypersensitivities 
to the antigens could occur is also greater. The present 
experiment does not indicate any grave hazards in transfusion 
of incompatible blood even on a repeat basis. On three occa- 
sions cats were given incompatible blood to which they had 
already been sensitized and no adverse effects were noted. 
The safety may be real, but in this experiment all cats were 
healthy at the time of transfusion and the volumes used were 
much smaller than those of clinical transfusions. These 
transfusions were also done in anesthetized cats and con- 
sisted of cells reconstituted in sterile saline, thus removing 
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foreign serum antigens. Because there are reports of pro- 
blems, the matter of safety should not be viewed as 
unimportant. 
This experiment indicates, as does clinical experience, 
that transfusions in the cat can provide the oxygen carrying 
erythrocytes with a high degree of viability and relative 
safety. Further, unlike other species5,6,11,12 the erythro- 
cytes can be quite long lived due to the single red cell 
antigen system of cats. If feline blood groups are distri- 
buted in the United States similar to their distribution in 
other countries,17 there should be a high rate (37.5%) of 
incompatible transfusions done when donors are chosen ran- 
domly but a much smaller rate of repeated incompatible trans- 
fusions. Primary incompatible transfusions will apparently 
provide benefit to the patient for a significant period of 
time but are potentially more hazardous. The potential 
hazards can be minimized by blood typing of cats or in some 
cases through simple crossmatches. For maximum benefit, 
especially in treating chronic anemias where bone marrow 
response is poor, cats should be transfused with cells of 
the same blood group or at least not transfused with cells 
to which they have been previously sensitized. 
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Figure 1. Percentage of transfused erythrocytes 
surviving, determined by counts/min as 
a percent of the 24 hr counts. Results 
of four autologous transfusions. 
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Figure 2. Percentage of transfused erythrocytes surviving, 
determined by counts/min as a % of the 24 hr 
radioactivity counts. ---- Transfusion between 
cats of the same blood group, 0---0 between cats 
of different groups not previously transfused 
and A---* repeated between cats of different 
groups. 
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Paper 2. Post -Transfusion Viability of Feline 
Red Blood Cells Stored in ACD at 4° C 
35 
Summary 
The 24 -hour post -infusion erythrocyte viability was 
determined in feline blood stored in acid -citrate -dextrose 
(ACD) solution "B" with 51Cr-labeling. Viability decreased 
significantly (p < .01) during 40 days of storage. Feline 
blood can be stored in ACD at 4° C for 30 days and retain high 
erythrocyte viability. 
Introduction 
The use of stored blood for transfusions in cats, although 
not a common technique, may, under certain circumstances, be 
the most convenient alternative. It allows more efficient 
use of blood from sacrifical cats and may eliminate the cost 
of maintaining a donor cat. If stored blood is to be used, 
it is important to know the length of time that the red cells 
can be kept while retaining their viability. 
Erythrocyte viability limits storage of human blood. 
Post -storage viability is defined as the percent of transfused 
red blood cells present in the circulation 24 hours after the 
transfusion, as determined by radioactive chromate labeling. 
The National Institute of Health (NIH) recommends that at 
least 70% of the transfused cells be viable at 24 hours; 
therefore, human blood stored in acid -citrate -dextrose (ACD) 
is limited to three weeks. In some countries, ACD has been 
replaced by solutions containing adenine or phosphate for 
human blood storage, but it remains a widely used, widely 
available and efficient media for blood storage. 
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Post -storage viability of stored feline blood is unknown. 
It has been assumed that cats will follow closely the results 
obtained with dogs. Canine blood remains viable for up to four 
weeks in ACD at 4° C,1 but recommendations for maximum storage 
rarely go beyond the human standard of 21 days.2 
Materials and Methods 
Four domestic shorthair cats were used in this study. 
One was an intact male, the other three intact females. The 
cats weighed between 8 and 12 lbs. 
ACD solution "B" was prepared and sterilized by passage 
through a .22um membrane filter.a 
Blood (30 ml) was removed from each donor by jugular 
venipuncture and added to the anticoagulant at a ratio of 4 ml 
of blood to 1 ml of ACD in 150 ml plastic bags.b The bags were 
mixed by gentle rotation biweekly while being stored at 4°C. 
Approximately 1 hour after collection and every 10 days 
thereafter 5 ml of the blood -anticoagulant mixture was drawn 
into syringes. Radioactive sodium chromatec (25 pCi) was 
added to the mixture. After a 30 minute incubation at 37°C, 
ascorbic acid (50 mg) was added to terminate the labeling 
process. Cells were washed 3 times with equal volumes of 
sterile isotonic saline, and suspended in 5 mis of isotonic 
saline. 
aMillex, G. S. Millipore Corporation, Bedford, Mass. 
bViaflex, Travenol Laboratories, Inc., Deerfield, Ill. 
cRadioactive 
sodium chromate, Amersham/Searle, Arlington 
Heights, Ill. 
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Labeled blood samples were infused into each cat via a 
cephalic catheter.d Blood samples (1 ml) were taken from 
the jugular veins just prior to transfusion, at 30 minutes 
post -transfusion and at 24 hours post -transfusion. The radio- 
activity of whole blood samples were counted in a well type 
gamma counter and reported as counts/min/ml. The 24 -hour 
post -transfusion viability percentages were calculated using 
the radioactivity of the 30 minute sample as 100% and com- 
paring it to the 24 -hour post -infusion radioactivity. The 
counts were corrected for the radioactivity present from the 
previous weeks experiment. Experimental data were analyzed 
by analysis of variance, with the significant effects of time 
localized by least significant difference (LSD). 
Results and Discussion 
The 24 -hour post -transfusion viability of feline red 
blood cells, stored in ACD, decreased significantly by the 
40th day of storage (p < .01). Visible hemolysis became 
apparent by the end of the fifth week. 
The data presented here indicate that cat whole blood 
can be stored up to 40 days in ACD solution "B" at 4°C and 
mtaintain a high degree of viability (> 70%). It is note- 
worthy that using the same criteria recommendation for storage 
of dog blood is 21 days.2 It appears from this data that cat 
blood storage can be extended to 1 month. 
dSovereign indwelling catheter, Sherwood Medical, 
St. Louis, Mo. 
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Most transfusions in cats are not given in emergency 
situations, but rather used in the treatment of acute or 
chronic anemias.3 The ability to use stored blood is, there- 
fore, probably more of a convenience than a necessity, but 
with the availability of blood from cats to be euthanized 
and the length of storage possible, it can be an attractive 
alternative. 
Questions have been raised about the safety of citrate 
anticoagulant use in the cat.4 Citrate toxicity occurs in 
dogs and humans5'6 when large amounts of citrated blood are 
infused. Many transfusions have been performed in cats using 
citrate anticoagulant with apparent safety but the problem 
needs further study. 
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Figure 1. Post -storage viability of feline erythrocytes 
stored in ACD at 4°C (S.D. = 3.87). The NIH 
minimum standard is indicated at the 70% level. 
80-, 
41 
60- 
Q, 40- c, 
o 
0 
0 
tn 
0 
20- 
7C0/0 
0 
0 10 20 30 40 50 
Days of Storage 
42 
APPENDIX 
Autologous 1 
Sample (days) Counts avg. %24 hr. count Hb. 
43 
Hot. 
1 972 100 11.2 40 
2 765 79 11.4 38 
4 731 75 11.4 38 
7 690 71 11.3 38.5 
10 740 76 11.2 39 
14 679 70 11.3 39.5 
17 643 66 11.4 38.5 
21 641 66 11.5 38 
24 634 65 11.4 40 
28 589 61 11.4 40.5 
34 583 60 11.5 40 
38 486 50 11.5 40.5 
42 410 42 11.5 41.5 
45 342 35 11.6 39.5 
49 271 28 11.4 39.5 
54 276 28 11.4 40 
60 148 15 11.3 40 
63 116 12 11.2 38.5 
68 92 10 11.3 39 
7o 38 4 11.0 39.5 
Autologous 2 
1 1154 100 9.8 36 
2 983 85 9.4 36.5 
5 1097 95 9.6 35.5 
8 98o 85 9.6 37 
13 785 68 10.1 37.5 
16 851 74 10.0 36.5 
19 807 70 10.2 37.5 
25 831 72 10.1 36 
29 903 78 9.6 38 
35 577 50 9.8 37.5 
142 5r6 5.0 9.4 38.5 
Table 1 - Daily radioactivity data, hemoglobin and hematocrit 
values for 4 autologous and 7 allogeneic transfusions. 
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Autologous 3 
Sample (days) Counts avg. %24 hr. count Hb. Hct. 
1 231 100 10.2 38.5 
2 208 90 10.0 38.5 
4 214 92 10.3 36 
8 217 93 9.9 36.5 
10 211 91 9.9 35.5 
13 181 78 10.0 35 
16 184 80 10.1 35 
19 179 78 10.4 35 
24 182 78 10.4 36.5 
29 141 62 10.5 36 
33 111 49 10.3 37 
4o 138 6o 10.2 36 
44 130 57 10.4 36 
46 103 45 10.0 35.5 
53 105 45 10.7 36.5 
59 78 34 1C.5 37.5 
6o 79 34 10.5 37 
64 28 12 10.5 38.5 
68 34 15 10.7 38 
72 20 9 10.7 39 
74 19 9 10.9 37 
8o 3 1 10.7 39 
Autologous 4 
1 179 100 11.2 41.5 
2 146 81 11.2 41 
4 150 85 11.0 39 
7 132 73 10.9 39.5 
10 120 67 10.9 38.5 
13 130 73 10.6 36 
17 125 70 10.8 36 
24 122 67 10.9 37 
29 119 67 10.3 37.5 
36 111 62 10.4 36 
39 81 45 10.3 34 
42 90 51 10.3 35 
50 8o 45 10.0 35.5 
X45 
53 59 33 10.3 34.5 
58 53 29 10.3 34.5 
6o 55 31 10.1 35 
68 52 29 10.4 34 
72 29 16 10.3 36.5 
74 25 14 10.3 36 
8o 4 2 10.7 36 
Sample (days) 
Allogeneic 1 
Counts avg. %24 hr. count Hb. Hct. 
1 63 100 12.4 40 
2 51 80 12.2 39 
3 52 83 10.9 39.5 
5 61 97 12.0 38 
8 42 66 11.6 38 
13 43 68 11.8 39 
15 28 44 10.6 38 
18 19 29 11.8 39.5 
20 8 12 12.1 39.5 
23 4 6 12.4 40.5 
25 1 2 12.3 39 
Allogeneic 2 
1 200 100 11.6 41 
2 192 96 11.8 41 
4 204 102 11.5 40 
7 144 72 11.5 41.5 
10 146 73 11.6 41.5 
13 150 75 11.9 40.5 
16 144 73 11.8 39.5 
19 124 62 11.7 39 
28 108 54 11.6 39.5 
33 94 47 11.5 38.5 
39 70 35 11.4 38 
42 58 29 11.2 38 
46 54 27 11.4 38.5 
53 30 15 11.3 39.5 
58 38 19 11.1 38 
6o 8 4 11.1 38 
64 4 2 11.3 37.5 
Allogeneic 3 
Sample (days) Counts avg. %24 hr. count Hb. 
46 
Hct. 
1 229 100 11.9 37.5 
2 224 98 11.4 38 
4 183 8o 10.6 36,5 
7 142 62 10.8 37.5 
10 121 53 11.6 36.5 
13 23 10 11.4 37 
16 2 1 11.0 37 
Allogeneic 4 
1 343 100 11.2 39 
2 202 59 10.6 38 
4 134 39 11.8 38 
6 93 27 10.8 39.5 
8 58 17 11.6 37 
10 41 12 11.4 37 
13 21 6 12.2 39 
15 27 8 12.4 40.5 
18 10 3 12.2 40.5 
20 10 3 11.6 41 
Allogeneic 5 
1 1238 100 11.1 33.5 
2 1263 102 10.6 35 
4 1139 92 10.5 35 
6 1111 90 9.6 36 
8 1102 89 11.1 36.5 
10 1139 92 10.9 35.5 
13 830 67 11.2 37 
15 124 10 10.6 35 
18 74 6 10.2 36 
20 25 2 10.8 36 
Allogeneic 6 
Sample (days) Counts avg. %24 hr. count Hb. 
47 
Hct. 
1 323 100 12.2 39 
2 325 100 11.9 38 
3 216 67 11.6 39.5 
4 101 31 12.2 38.5 
6 7 2 10.9 37 
Allogeneic 7 
1 883 100 10.8 34 
2 769 87 11.1 33 
3 710 8o 10.8 35.5 
4 662 75 11.4 34 
5 88 10 11.2 34 
6 35 4 10.8 32.5 
Cat 18 
Storage (days) 30 min count 24 hr count 24 hr % 
48 
Hb. 
1 1452 1249 86 9.0 
10 1559 1340 86 9.4 
20 1866 1720 92 8.8 
3o 1367 1179 86 8.6 
40 6402 5028 79 8.8 
Cat 19 
1 825 805 98 10.5 
10 940 788 84 10.3 
20 1320 1078 82 10.7 
30 772 715 93 10.4 
4o 3471 2594 75 10.8 
Cat 20 
1 1173 1119 95 10.8 
10 1323 1166 88 11.2 
20 1523 1387 91 11.3 
30 967 832 86 10.9 
40 4042 2712 67 11.5 
Cat 21 
1 1189 983 83 10.4 
10 1288 1184 92 11.2 
20 1267 1112 88 11.4 
30 1035 776 75 11.5 
40 4861 2829 58 11.1 
Table 2 - 24 hr post -storage viability data and hemoglobin 
values for 4 cats. 
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Whole blood transfusion is a widely used therapeutic 
procedure in cats, but little is known about the hemodynamics 
and complications of the transfusion and the effect of feline 
blood groups on the safety and efficacy of the process. 
Autologous transfusion in other species and transfusion 
between compatible humans provides red cells with near normal 
life -spans, while allogeneic transfusion in animals can result 
in shortened life -span of transfused erythrocytes. Problems 
of red cell incompatibilities, transfusion reactions, and 
neonatal isoerythrolysis, have been associated with blood 
group antigens and antibodies in most species studied, but 
reports in the cat are few. There are only three blood groups 
known in cats. The population consists of 75% group A, 25% 
group B, and .4% group AB. 
Apparent mean survival time of 14C-cyanate labeled feline 
erythrocytes was determined after autologous and allogeneic 
transfusion. Mean survival time was defined as that time when 
one half of the transfused cells have been removed from cir- 
culation. Autologously transfused cells had a mean survival 
time of 38.0 days + 2.02. Allogeneic transfusion between 
cats of the same blood type showed a near normal mean sur- 
vival time of 30 days. Primary allogeneic transfusion between 
cats of differing blood groups showed a mean survival time 
between 10 and 14 days, while repeat transfusions of this type 
showed a mean survival time of less than 5 days. The life - 
span of cross -transfused red cells can be significantly 
affected by blood type. For maximum effectiveness, survival 
of cells, blood transfusions should be between cats of the 
same blood type. First-time transfusions between cats of 
differing blood types can be given safely but erythrocyte 
life -span will be shortened. 
The 24 -hour post -infusion erythrocyte viability was 
determined in feline blood stored in acid -citrate -dextrose 
(ACD) solution "B" with 51Cr-labeling. Viability decreased 
significantly (p < .01) during 40 days of storage. Feline 
blood can be stored in ACD at 4°C for 30 days and retain high 
erythrocyte viability. 
